REMS Review: Barriers to Actionable Data Collection
September 25th 2013Manufacturers often select their specialty drug distribution strategy based on the level of REMS reporting required by the FDA. What are some things keeping specialty pharmacies and manufacturers from collecting the data they truly want?
Read More